Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Sensus Healthcare, Inc. (SRTS)

NCM · Medical Devices

$2.94-0.08 (-2.65%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$48.4M
P/E (TTM)
EPS
$-0.46
Div Yield
52W Range
$2.66–$5.92
Beta
1.09

Company overview

Next earnings: 2026-08-06(9d)

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

Peers in Medical Devices

All in industry →

Recent press releases

Sensus Healthcare, Inc. has not issued a press release in this window.

SEC filings

All filings →

Sensus Healthcare, Inc. has not filed an SEC document in this window.

Sensus Healthcare, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
728,916 sh0.0%
128,774 sh● NEW
125,586 sh● NEW
70,159 sh+275.2%
257,034 sh-1.6%
148,508 sh+6.8%

People at Sensus Healthcare, Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$8.3M
NI -$2.6M
06/25
$7.3M
NI -$1.0M
09/25
$6.9M
NI -$943.0K
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.06
Prior: $-0.06
Revenue sparkline